{"_id":"X1XwMMob78YdXjL0iAtStWlKYuxJH855Xp3Iks0QLSd5l54zCeaLTq","founded_year":1886,"lastupdate":"2024-02-04T00:00:00.000Z","update_date":"2024-02-04T00:00:00.000Z","lastModified":"Feb 4, 2024","confidence_score":37,"active":1,"confidence_score_reason":"funding stage, product stage, sector, tags, invite member, business model, homepage, video or image, funding rounds, news, markets, external profiles, not claimed","urlname":"menarini-group","minimal_profile":null,"status":"","fullstatus":null,"acquired":null,"description_edited":null,"tag_line_edited":null,"phone":null,"registrar":null,"biverification":null,"recentupdates":[{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-02-04 14:40:06.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-02-04 14:40:08.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2024-02-04 14:40:21.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Automatic","datetime":"2024-02-04 14:40:08.000000","last_name":"Perlov","first_name":"Maor"}],"sectorverify":null,"biverify":null,"biverifydate":null,"crunchbaseid":null,"lastupdator":null,"lastupdator_email":null,"creator":"Maor Perlov","creator_email":"maor.perlov@sncentral.org","createdate":"2024-02-04T00:00:00.000Z","lastupdatedate":"2024-02-04","hide_reason":"hoyKAmu4YJEHmhtLwCdeFldSnDwaVbPXOnH0RA9hKHCzAcHO6OOrXd","hide_reason_data":{"reason":"Pending approval","visible":1},"logokey":"$rKB1HV1lcm4X4YROUtEaW4OqsC5vnYKoaURSjt61DeXyg1mmy3U52B.jpeg","name":"MENARINI Group","israeliacquisitions":0,"forbesranking":null,"investmentarm":null,"investmentarmname":null,"hubname":null,"acquired_amount":null,"acquired_by":null,"acquired_country":null,"acquired_month":null,"acquired_year":null,"type":"Multinational","formernames":[],"alternativenames":null,"country":"Italy","inisraelsince":"1/2024","inisraelsincemonth":"1","isisraeli":0,"marketcapital":null,"marketcapitaldate":null,"oneliner":"Pharmaceuticals","website":"","employees":"1-10","employees_exact":6,"employees_overall":"5,001-10,000","employees_overall_exact":10000,"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"","instagram":""},"social":[],"flattenedsociallinks":null,"apps":{"appstore":"","googleplay":""},"investmentstage":[],"about":"The Menarini Group is a pharmaceutical and diagnostics company, present in 140 countries worldwide.\n\nWith 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics.\n\nThe Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 578 million packets of product a year and distribute them to five continents.","founded":"1/1886","team":[],"portfolio":[],"exits":[],"mediagallery":[],"affiliatedOrganizations":null,"address":{"israeli":null,"officesabroad":[{"id":"xdtXFPhS6AS1NJr7WuvnE8EEtcXZ5KJKWnebp6dAh0ifS0On3vrEU5","city":null,"address":"Naples, Metropolitan City of Naples, Italy","country":"Italy","placeid":"ChIJmX5sak8IOxMRHRl4O8Es9T0"}]},"headquarter_address":null,"news":[{"id":"GFgxxyQNVEMRNKSJHSaYNXebU4KdGwwTytNecipGat7JeYqOgrPPTI","date":"May 4, 2020","link":"https://www.globenewswire.com/en/news-release/2020/05/04/2026614/21662/en/Menarini-Group-to-Acquire-Stemline-Therapeutics-in-Transaction-Valued-at-Up-to-677-Million.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"Acquisition, Expansion","company":"Menarini Group, Stemline Therapeutics Inc.","layoffs":"Not mentioned","summary":"Menarini Group, an Italian pharmaceutical and diagnostics company, has announced a definitive agreement to acquire Stemline Therapeutics Inc., a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The acquisition, valued up to $677 million, will establish Menarini’s presence in the U.S. biopharmaceutical oncology market and support further development of Stemline’s ELZONRIS®. The transaction is expected to close in the second quarter of 2020.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not Applicable","confidence":9,"key_topics":"Acquisition, Oncology Therapeutics, Global Expansion, Regulatory Approval, Commercialization","date_of_event":"May 04, 2020","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not Applicable","structured_issues":"Acquisition, Expand","acquisition_amount":"$677 million","structuredIssuesShow":"#Acquisition, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"nsa48UeopW88h8Ftm9xOmGiQcz2VWNYObsQfrlas31vXtpt3J8LERv","news_summary":"Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"extensions":null,"events":null,"hide_reasons":[{"id":"75T5aG1f0dpqYFonup40lXNjO046zUH82TaHW1TAiIMf9aYAsSOl0d","reason":"No relevant activity"},{"id":"7KVi9S7qqUtO0WCsFclwqBEZluejfNYqWC1Uhx0tPHtDxtvxPPaCPH","reason":"No longer active"},{"id":"hoyKAmu4YJEHmhtLwCdeFldSnDwaVbPXOnH0RA9hKHCzAcHO6OOrXd","reason":"Pending approval"},{"id":"TC54H7CXyKO8GmPECkbyKJf8n34r70JlfJTJHfo85exRpLaKI1Efs9","reason":"Pending approval - External entity"}],"timeline":[],"techcommunityinvolvement":null,"tags":[],"investments":[],"funds":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"5,001-10,000","fundingtype":"Multinational","parsedName":"MENARINI Group","logourl":"https://storage.googleapis.com/clean-finder-353810/$rKB1HV1lcm4X4YROUtEaW4OqsC5vnYKoaURSjt61DeXyg1mmy3U52B.jpeg","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$rKB1HV1lcm4X4YROUtEaW4OqsC5vnYKoaURSjt61DeXyg1mmy3U52B.jpeg","teamMembersNumber":0,"nationality":"Foreign","communityinvolvement":[],"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}